Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention
One in ten people undergoing percutaneous coronary intervention (PCI) has underlying atrial fibrillation (AF). They are often treated with long-term oral anticoagulation for stroke prevention and are commenced on antiplatelet therapy post-PCI to prevent stent thrombosis.1 A careful balance of risk o...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 29, 2020
|
| In: |
Heart
Year: 2020, Jahrgang: 106, Heft: 17, Pages: 1293-1295 |
| ISSN: | 1468-201X |
| DOI: | 10.1136/heartjnl-2020-316726 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/heartjnl-2020-316726 Verlag, lizenzpflichtig, Volltext: https://heart.bmj.com/content/early/2020/05/29/heartjnl-2020-316726 
|
| Verfasserangaben: | Samer Al Said, Hugo A. Katus, Samer Alabed |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1737997096 | ||
| 003 | DE-627 | ||
| 005 | 20220819013507.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201105s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/heartjnl-2020-316726 |2 doi | |
| 035 | |a (DE-627)1737997096 | ||
| 035 | |a (DE-599)KXP1737997096 | ||
| 035 | |a (OCoLC)1341375857 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Al Said, Samer |d 1988- |e VerfasserIn |0 (DE-588)110439569X |0 (DE-627)861820630 |0 (DE-576)470964227 |4 aut | |
| 245 | 1 | 0 | |a Cochrane corner |b NOACs in atrial fibrillation patients post-percutaneous coronary intervention |c Samer Al Said, Hugo A. Katus, Samer Alabed |
| 264 | 1 | |c May 29, 2020 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.11.2020 | ||
| 520 | |a One in ten people undergoing percutaneous coronary intervention (PCI) has underlying atrial fibrillation (AF). They are often treated with long-term oral anticoagulation for stroke prevention and are commenced on antiplatelet therapy post-PCI to prevent stent thrombosis.1 A careful balance of risk of bleeding versus thrombosis is essential. - - Options for oral anticoagulation include vitamin K antagonists (VKAs), for example, warfarin, and non‐vitamin K antagonist oral anticoagulants (NOACs), also referred to as direct oral anticoagulants. In contrast to VKA, NOACs directly inhibit either thrombin (dabigatran) or factor X (rivaroxaban, apixaban and edoxaban). Recent randomised controlled trials (RCTs) have compared NOACs with warfarin in patients with AF undergoing PCI. We reviewed these RCTs to summarise their efficacy and safety results.2 One of our aims was also to compare NOACs with each other; however, no RCT conducted such a comparison. We, therefore, performed a network meta-analysis to compare NOACs indirectly. A network meta-analysis is a unique statistical technique that facilitates indirect comparisons of interventions based on a common comparator across trials, that is, warfarin, in our analysis (figure 1). - - - - Figure 1 - Network diagram for major bleeding. Nodes are weighted according to the number of studies that includes the respective intervention. Edges are weighted according to the number of patients included in the respective comparison. Numbers on the lines represent the number of trials … | ||
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Alabed, Samer |e VerfasserIn |0 (DE-588)1220875066 |0 (DE-627)1738002950 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heart |d [London] : BMJ Publ. Group, 1996 |g 106(2020), 17, Seite 1293-1295 |h Online-Ressource |w (DE-627)269538925 |w (DE-600)1475501-4 |w (DE-576)078940427 |x 1468-201X |7 nnas |a Cochrane corner NOACs in atrial fibrillation patients post-percutaneous coronary intervention |
| 773 | 1 | 8 | |g volume:106 |g year:2020 |g number:17 |g pages:1293-1295 |g extent:3 |a Cochrane corner NOACs in atrial fibrillation patients post-percutaneous coronary intervention |
| 856 | 4 | 0 | |u https://doi.org/10.1136/heartjnl-2020-316726 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://heart.bmj.com/content/early/2020/05/29/heartjnl-2020-316726 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201105 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |d 50000 |e 910000PK108916618 |e 910100PK108916618 |e 50000PK108916618 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 | ||
| 998 | |g 110439569X |a Al Said, Samer |m 110439569X:Al Said, Samer |d 910000 |d 910200 |e 910000PA110439569X |e 910200PA110439569X |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1737997096 |e 3792706970 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"269538925","origin":[{"publisher":"BMJ Publ. Group","dateIssuedDisp":"1996-","dateIssuedKey":"1996","publisherPlace":"[London]"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1468-201X"],"eki":["269538925"],"zdb":["1475501-4"]},"title":[{"title_sort":"Heart","title":"Heart"}],"note":["Gesehen am 12.12.12"],"pubHistory":["75.1996 -"],"part":{"issue":"17","extent":"3","pages":"1293-1295","text":"106(2020), 17, Seite 1293-1295","volume":"106","year":"2020"},"language":["eng"],"titleAlt":[{"title":"Heart and Education in Heart"},{"title":"Education in heart"},{"title":"Heart online"}],"disp":"Cochrane corner NOACs in atrial fibrillation patients post-percutaneous coronary interventionHeart","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"May 29, 2020","dateIssuedKey":"2020"}],"title":[{"title_sort":"Cochrane corner","title":"Cochrane corner","subtitle":"NOACs in atrial fibrillation patients post-percutaneous coronary intervention"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1737997096"],"doi":["10.1136/heartjnl-2020-316726"]},"physDesc":[{"extent":"3 S."}],"person":[{"family":"Al Said","role":"aut","display":"Al Said, Samer","given":"Samer"},{"display":"Katus, Hugo","given":"Hugo","family":"Katus","role":"aut"},{"role":"aut","family":"Alabed","display":"Alabed, Samer","given":"Samer"}],"recId":"1737997096","note":["Gesehen am 05.11.2020"],"language":["eng"],"name":{"displayForm":["Samer Al Said, Hugo A. Katus, Samer Alabed"]}} | ||
| SRT | |a ALSAIDSAMECOCHRANECO2920 | ||